# Fludeoxyglucose F18

NDC: 24562-003
Generic name: Fludeoxyglucose F-18
Labeler / Manufacturer: Biomedical Research Foundation of Northwest Louisiana
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20150514

FDA application: ANDA203837

## Active ingredients

- FLUDEOXYGLUCOSE F-18: 300 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24562-003"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24562-003
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=edb15e3c-848d-433d-9f1c-c73a3c72861b